Trading Bio-Tbio Ltd 14526528 false 2022-12-07 2023-12-31 2023-12-31 The principal activity of the company is Wholesale of other fuels and related products Digita Accounts Production Advanced 6.30.9574.0 true 14526528 2022-12-07 2023-12-31 14526528 2023-12-31 14526528 bus:Director1 2023-12-31 14526528 bus:Director2 2023-12-31 14526528 bus:Director3 2023-12-31 14526528 bus:OrdinaryShareClass1 2023-12-31 14526528 core:RetainedEarningsAccumulatedLosses 2023-12-31 14526528 core:ShareCapital 2023-12-31 14526528 core:CurrentFinancialInstruments 2023-12-31 14526528 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 14526528 bus:SmallEntities 2022-12-07 2023-12-31 14526528 bus:AuditExemptWithAccountantsReport 2022-12-07 2023-12-31 14526528 bus:AbridgedAccounts 2022-12-07 2023-12-31 14526528 bus:SmallCompaniesRegimeForAccounts 2022-12-07 2023-12-31 14526528 bus:RegisteredOffice 2022-12-07 2023-12-31 14526528 bus:CompanySecretary1 2022-12-07 2023-12-31 14526528 bus:Director1 2022-12-07 2023-12-31 14526528 bus:Director2 2022-12-07 2023-12-31 14526528 bus:Director3 2022-12-07 2023-12-31 14526528 bus:OrdinaryShareClass1 2022-12-07 2023-12-31 14526528 bus:PrivateLimitedCompanyLtd 2022-12-07 2023-12-31 14526528 core:RetainedEarningsAccumulatedLosses 2022-12-07 2023-12-31 14526528 core:ShareCapital 2022-12-07 2023-12-31 14526528 countries:AllCountries 2022-12-07 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 14526528

Trading Bio-Tbio Ltd

Annual Report and Unaudited Abridged Financial Statements

for the Period from 7 December 2022 to 31 December 2023

 

Trading Bio-Tbio Ltd

Contents

Company Information

1

Directors' Report

2

Abridged Statement of Financial Position

3

Statement of Changes in Equity

4

Notes to the Unaudited Abridged Financial Statements

5 to 6

 

Trading Bio-Tbio Ltd

Company Information

Directors

Pietro Marini

Pietro Marseglia

Company secretary

Lincoln Secretaries Limited

Registered office

12 Bridewell Place,
London
England
EC4V 6AP

 

Trading Bio-Tbio Ltd

Directors' Report for the Period from 7 December 2022 to 31 December 2023

The directors present their report and the abridged financial statements for the period from 7 December 2022 to 31 December 2023.

Incorporation

The company was incorporated and commenced trading on 7 December 2022.

Directors of the company

The directors who held office during the period were as follows:

Pietro Marini (appointed 7 December 2022)

Pietro Marseglia (appointed 7 December 2022)

Silvia Baldassarre (appointed 7 December 2022 and ceased 24 February 2023)

Principal activity

The principal activity of the company is Wholesale of other fuels and related products

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 7 March 2023 and signed on its behalf by:
 

.........................................
Lincoln Secretaries Limited
Company secretary

 

Trading Bio-Tbio Ltd

(Registration number: 14526528)
Abridged Statement of Financial Position as at 31 December 2023

Note

2023
$

Current assets

 

Debtors

4

683,903

Cash at bank and in hand

 

2,456,587

 

3,140,490

Creditors: Amounts falling due within one year

(752,692)

Total assets less current liabilities

 

2,387,798

Accruals and deferred income

 

(3,183)

Net assets

 

2,384,615

Capital and reserves

 

Called up share capital

5

153

Retained earnings

2,384,462

Shareholders' funds

 

2,384,615

For the financial period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Income Statement and an Abridged Statement of Financial Position in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 7 March 2023 and signed on its behalf by:
 

.........................................
Pietro Marini
Director

 

Trading Bio-Tbio Ltd

Statement of Changes in Equity for the Period from 7 December 2022 to 31 December 2023

Share capital
$

Retained earnings
$

Total
$

Profit for the period

-

2,384,462

2,384,462

New share capital subscribed

153

-

153

At 31 December 2023

153

2,384,462

2,384,615

 

Trading Bio-Tbio Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 7 December 2022 to 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
12 Bridewell Place,
London
England
EC4V 6AP

These financial statements were authorised for issue by the Board on 7 March 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Trading Bio-Tbio Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 7 December 2022 to 31 December 2023

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 0.

4

Debtors

Debtors includes $Nil due after more than one year.

5

Share capital

Allotted, called up and fully paid shares

 

2023

 

No.

$

Ordinary of $1.27 each

120

153